Infectious diseases are commonly implicated as potential initiators of autoimmune diseases
(ADs) and represent the most commonly known factor in the development of autoimmunity in …

Long COVID (LC) is a condition in which patients do not fully recover from the initial SARS-
CoV-2 infection but rather have persistent or new symptoms for months to years following …

One in ten severe acute respiratory syndrome coronavirus 2 infections result in prolonged
symptoms termed long coronavirus disease (COVID), yet disease phenotypes and …

As the heterogeneity of symptoms is increasingly recognized among long-COVID patients, it
appears highly relevant to study potential pathophysiological differences along the different …

Background Chorioamnionitis alters neonatal immune responses. Gestational COVID-19
infection is associated with adverse pregnancy outcomes, but its impact on neonatal …

Since the onset of the COVID-19 pandemic, significant progress has been made in
developing effective preventive and therapeutic strategies against severe acute SARS-CoV …

Long COVID, also known as post-acute sequelae of SARS-CoV-2 infection (PASC), has
emerged as a significant health concern following the COVID-19 pandemic. Molecular …

Long COVID is the name given to a syndrome comprising a wide variety of symptoms
persisting more than 3 months after acute benign COVID-19, with a prevalence ranging from …

As COVID-19 continues, an increasing number of patients develop long COVID symptoms
varying in severity that last for weeks, months, or longer. Symptoms commonly include …

Innate immune memory endows innate immune cells with antigen independent heightened
responsiveness to subsequent challenges. The durability of this response can be mediated …